A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease
Clinical trial NCT07068165 · RECRUITING
Trial details
- NCT number
- NCT07068165
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-07
- Primary completion
- 2028-07-20
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.